TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer

Author: Moretti Erica   Desmedt Christine   Biagioni Chiara   Regan Meredith M   Oakman Catherine   Larsimont Denis   Galardi Francesca   Piccart-Gebhart Martine   Sotiriou Christos   Rimm David L   Di Leo Angelo  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.9, Iss.10, 2013-10, pp. : 1477-1487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content